TNSN05047A1 - Inhalation composition - Google Patents

Inhalation composition

Info

Publication number
TNSN05047A1
TNSN05047A1 TNP2005000047A TNSN05047A TNSN05047A1 TN SN05047 A1 TNSN05047 A1 TN SN05047A1 TN P2005000047 A TNP2005000047 A TN P2005000047A TN SN05047 A TNSN05047 A TN SN05047A TN SN05047 A1 TNSN05047 A1 TN SN05047A1
Authority
TN
Tunisia
Prior art keywords
microns
particles
diameter
less
inhalation composition
Prior art date
Application number
TNP2005000047A
Inventor
Xian-Ming Zeng
Original Assignee
Norton Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9942746&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TNSN05047(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Norton Healthcare Ltd filed Critical Norton Healthcare Ltd
Publication of TNSN05047A1 publication Critical patent/TNSN05047A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention provides a dry powder inhalation composition comprising medicament particles and a mixture of laclose particles with a VMD of between about 70 and about 120 microns and a diameter of less than 250 microns, the mixture being characterized in that up to 96% by weight of the lactose particles are less than 150 microns in diameter and wherein up to 25% by weight of the lactose particles are less than 5 microns in diameter. The compositions provide for a more accurate, uniform and consistent dispersion when used with, for example, a multidose dry powder inhaler. Also disclosed are methods for use of the compositions of the invention.
TNP2005000047A 2002-08-21 2005-02-18 Inhalation composition TNSN05047A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0219513A GB0219513D0 (en) 2002-08-21 2002-08-21 Inhalation compositions including coarse carrier
PCT/US2003/026385 WO2004017914A2 (en) 2002-08-21 2003-08-21 Inhalation composition

Publications (1)

Publication Number Publication Date
TNSN05047A1 true TNSN05047A1 (en) 2007-05-14

Family

ID=9942746

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2005000047A TNSN05047A1 (en) 2002-08-21 2005-02-18 Inhalation composition

Country Status (8)

Country Link
BR (1) BRPI0313647A2 (en)
CA (1) CA2499273C (en)
ES (1) ES2371601T3 (en)
GB (1) GB0219513D0 (en)
NO (1) NO20051461L (en)
TN (1) TNSN05047A1 (en)
WO (1) WO2004017914A2 (en)
ZA (1) ZA200502177B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007533387A (en) 2004-04-21 2007-11-22 イノベータ バイオメド リミテッド Inhaler
BRPI0510119A (en) 2004-04-23 2007-09-25 Cydex Inc formulation for dpi containing sulfoaquil cyclodextrin ether
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
WO2006086270A1 (en) 2005-02-10 2006-08-17 Glaxo Group Limited Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
GB0605723D0 (en) * 2006-03-23 2006-05-03 3M Innovative Properties Co Powder filling processes
WO2008134817A1 (en) * 2007-05-03 2008-11-13 The University Of Sydney Composite carriers for dry powder inhalation therapy
TR201205852A2 (en) * 2011-06-02 2012-12-21 Bi̇lgi̇ç Mahmut Improved new dry powder formulation.
TR201105367A2 (en) * 2011-06-02 2012-12-21 Bi̇lgi̇ç Mahmut A dry powder formulation with improved flow properties.
US20150150802A1 (en) 2012-07-05 2015-06-04 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhaler compositions comprising long acting muscarinic antagonists
AU2013290616B2 (en) 2012-07-19 2016-03-10 Adamis Pharmaceuticals Corporation Powder feeding apparatus
JP6251667B2 (en) 2014-06-03 2017-12-20 アサヒカルピスウェルネス株式会社 Tablet-type immediate release preparation and method for producing the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226164B1 (en) * 1998-11-13 2008-05-28 Jagotec Ag Use of magnesium stearate in dry powder compositions suitable for inhalation and compositions suitable for inhalation
AU1786199A (en) * 1998-12-11 2000-07-03 Pharmachemie B.V. Pharmaceutical preparation for inhalation of an opioid
UA75375C2 (en) 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
HU226982B1 (en) 2000-10-12 2010-04-28 Boehringer Ingelheim Pharma Novel tiotropium-containing inhalation powder, process for its preperation and its use

Also Published As

Publication number Publication date
GB0219513D0 (en) 2002-10-02
WO2004017914A8 (en) 2005-07-07
ZA200502177B (en) 2006-05-31
CA2499273A1 (en) 2004-03-04
CA2499273C (en) 2011-06-21
WO2004017914A2 (en) 2004-03-04
ES2371601T3 (en) 2012-01-05
WO2004017914A3 (en) 2004-04-29
NO20051461L (en) 2005-05-20
BRPI0313647A2 (en) 2019-02-19

Similar Documents

Publication Publication Date Title
TNSN05047A1 (en) Inhalation composition
MXPA02012023A (en) Highly efficient delivery of a large therapeutic mass aerosol.
EP1599209A4 (en) Inhalation composition
AU2001293899A1 (en) Ihnalation particles incorporating a combination of two or more active ingredients
ATE271383T1 (en) POWDER FORMULATION FOR INHALATION
GB0425758D0 (en) Preparation of pharmaceutical compositions
JO2430B1 (en) Pharmaceuticall Formulations for Dry Powder Inhalers in the form of Hard- Pellets
WO2005079755A3 (en) Interleukin-13 antagonist powders, spray-dried particles, and methods
HUP0300499A2 (en) Pharmaceutical formulations for dry powder inhalers
MX9700034A (en) Inhalation composition.
TW200505483A (en) New medicament compositions based on anticholinergically-effective compounds and β-mimetics
WO2002043700A3 (en) Particles for use in a pharmaceutical composition
WO2004017918A8 (en) Method of preparing dry powder inhalation compositions
AU2002357457A1 (en) Powder for nasal administration of drugs
ZA202201322B (en) Pharmaceutical composition comprising ensifentrine
FI20002216A0 (en) Combination particles for asthma therapy
TW200730170A (en) Micronised azodicarbonamide, and the preparation and use thereof
EA200500387A1 (en) COMPOSITIONS FOR INHALATION WITH HIGH CONTENT OF MEDICINAL SUBSTANCES
EA200900464A1 (en) PHARMACEUTICAL COMPOSITION FOR INHALATION
MY140890A (en) New tiotropium containing powder formulation for inhalation
AU2002314972A1 (en) Compressible guaifenesin compositions and method for producing them
PL365736A1 (en) Bimodal dry powder formulation for inhalation
NZ509881A (en) Micronised pharmaceutical compositions containing colistin sulphomethate sodium